Absolutely, there is a ton of interest in the Vision trial results. We then have the final LuPIN results to be announced around October.
Should the Vision trial results show similar mOS, it would then be interesting to know the details of the co-sponsoring arrangement with Novartis. At a minimum I expect Novartis to help fund the P2 trials, but would a more significant agreement also be entered into prior to commencing these trials? Good times ahead.
- Forums
- ASX - By Stock
- NOX
- Ann: New Independent Trial Data Supports Potential of Veyonda
Ann: New Independent Trial Data Supports Potential of Veyonda, page-4
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
11.0¢ |
Change
0.014(14.6%) |
Mkt cap ! $32.14M |
Open | High | Low | Value | Volume |
9.2¢ | 11.5¢ | 9.2¢ | $53.30K | 518.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 48681 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 74195 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 48681 | 0.100 |
1 | 7253 | 0.099 |
1 | 3473 | 0.096 |
2 | 23340 | 0.092 |
1 | 10989 | 0.091 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 74195 | 4 |
0.115 | 256630 | 6 |
0.120 | 61648 | 3 |
0.125 | 447472 | 6 |
0.130 | 199760 | 1 |
Last trade - 15.45pm 23/08/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online